mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.04 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.04 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.04 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
-0.094 |
0.04 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.091 |
0.04 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.04 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.04 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.04 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.04 |